Childhood abuse history among male addicts in comparison with non-addict population

AbstractChild abuse is an important social and health problem in the world. Behavioral and psychological problems in adolescence and adulthood are the long term psychological effects of physical abuse. Behavioral problems such as aggression in adolescence and drug abuse are common in individuals who were abused in childhood. Nevertheless, there is no integrative study of childhood abuse in Iranian addicts. Therefore, this study investigates the childhood abuse in addicts with the purpose of planning a psychological treatment for these patients. The purpose of this study is the investigation of sexual, physical, emotional and verbal abuse in childhood in male addicts in comparison with non addict population. For this purpose, 100 male addicts who were referred to therapeutic institutes in 2009 and 100 non male addicts answered to Child Abuse Self Report Survey(CASRS). Data have been analyzed by descriptive and inferential statistics by SPSS 16.The results show a positive and significant relationship between child abuse experience and addiction in adulthood, and it can be concluded that The experience of abuse and neglect in childhood is one of the effective factors of addiction in adulthood

Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial

Satureja khuzestanica is an endemic plant of Iran that is widely distributed in the Southern part of the country. It has antioxidant properties and thus it seems to be useful in diseases related to oxidative stress such as diabetes and hyperlipidemia. The present study investigates the effect of S. khuzestanica supplement in metabolic parameters of hyperlipidemic patients with type 2 diabetes mellitus. Twenty-one hyperlipidemic patients with type 2 diabetes mellitus were randomized in a double blind, placebo controlled clinical trial to receive either S. khuzestanica (tablets contain 250 mg dried leaves) or placebo once a day for 60 days. Blood samples were obtained at baseline and at the end of the study. Samples were analyzed for levels of glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, thiobarbituric acid reactive substances (TBARS) as marker of lipid peroxidation and ferric reducing ability (total antioxidant power, TAP). Treatment of patients by S. khuzestanica for 60 days induced significant decrease in total cholesterol (P = 0.008) and LDL-cholesterol (P = 0.03) while increased HDL-cholesterol (P = 0.02) and TAP (P = 0.007) in comparison with the baseline values. S. khuzestanica did not alter blood glucose, triglyceride, creatinin and TBARS levels. In comparison with baseline values, no significant change was observed in blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, TBARS and TAP in placebo-treated group. Usage of S. khuzestanica as a supplement to drug regimen of diabetic type 2 patients with hyperlipidemia is recommended

Procedia Social and Behavioral Sciences Study of Faradarmani Therapy on Depression Level

Abstract Faradarmani is a kind of complementary and alternative medicine in Iran .The objective of this research, was survey of faradarmani effectiveness on depression. for this aim, in shape of an quasi-experimental design in6 weeks, the therapy was performed on the group of experiment and has compared the scores of pre and post test of Beck inventory. 110 persons in experimental group and 58 persons were considered as control group who were not under faradarmani. the results showed, there is meaningful difference between 2 groups statistically and after faradarmani the depression participants' scores have been decreased in Beck experiment (p = 0.007). Faradarmani had no costs and side effects and decreases the need of usual therapies

Procedia Social and Behavioral Sciences Study of Faradarmani Therapy on Schizophernia(A case study)

Abstract Faradarmani is a kind of complementary and alternative medicine in Iran. in shape of case study design in 8 months, the faradarmani therapy was performed on a woman with schizophrenia . Elham is a 40 years old woman and the diagnosis for her is acute undifferentiated schizophrenia, along with dysthymia. Her status during the period of therapy was closely observed by two psychiatrists, a neurologist, a general practitioner, an expert in clinical psychology, two faradarmani therapists and her family. And in order for determining her psychological components, the pre and post-test of MMPI II was taken use of. In the viewpoints of her doctors, psychologist, faradarmani therapists and her family, her improvements are essential. The MMPI II test, confirms the current normal psychological status of her.the results show that faradarmani had essential and noticeable effects on decreasing of schizophrenia and dysthymia symptoms. Faradarmani had no costs and side effects and decreases the need of usual therapies

Targeting dyslipidemia by herbal medicines : a systematic review of meta-analyses

Ethnopharmacological relevance: The worldwide increasing prevalence of dyslipidemia has become a global health concern. Various herbal remedies have been claimed to be effective for the treatment of dyslipidemia in traditional and folkloric medicine of different regions clinical trials have been conducted to investigate their efficacy. The aim of the current systematic review is to critically assess the meta-analyses of controlled trials (CT) evaluated herb medicines for dyslipidemia. Materials and methods: Relevant studies from Web of Science, PubMed, Scopus, and Cochrane Library databases based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist until January 2021 have been searched. All meta-analyses which pooled studies on the effect of herbal medicines on lipid profile including total cholesterol (TC), triglyceride (TG), and low-or high-density lipoprotein cholesterol (LDLC, HDL-C) were also included. Meta-analyses of in vitro, animal or observational studies were excluded. Results: The overall of 141 meta-analyses were revealed. Vegetable oils, phytosterols, tea, soy protein, nuts, and curcumin have been studied frequently among the herbal medicines. Among 13 meta-analyses on vegetable oils, the greater reduce of TC (18.95 mg/dl), LDL-C (16.24 mg/dl) and TG (13.69 mg/dl) were exhibited from sunflower oil. Furthermore, rice bran oil (6.65 mg/dl) increased HDL-C significantly. Phytosterols in 12 meta analyses demonstrated significant improvements in reducing TC, LDL-C and TG as 16.4, 23.7, and 8.85 mg/dl, respectively, and rise in HDL-C as 10.6 mg/dl. The highest reduction in serum level of TC, LDL-C and TG was reported while intake Green tea; 27.57, 24.75, and 31.87 mg/dl, accordingly within 9 meta-analyses. Average improvement of lipid profiles by 6 meta-analyses on plant proteins were 23.2, 21.7, 15.06, and 1.55 mg/dl for TC, LDL-C, TG, and HDL-C, respectively. Among 11 meta-analyses on nuts, almond showed better and significant alleviations in TC (10.69 mg/dl), walnut in LDL-C (9.23 mg/dl), pistachio in TG (22.14 mg/dl), and peanut in HDL-C (2.72 mg/dl). Overall, Curcumin, Curcuminoid, and Turmeric have resulted in the reduction of TC (25.13 mg/dl), LDL-C (39.83 mg/dl), TG (33.65 mg/dl), and an increase in the HDL-C (4.31 mg/dl). Conclusion: The current systematic review shed light on the use of herbal medicines for the management of dyslipidemia. However, more well-conducted CTs are required to determine effective doses of herbal medicines